- Home
- MED
MED
MEDIFAST INC
as 11-08-2024 1:35pm EST
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | OWINGS MILLS |
| Market Cap: | 213.6M | IPO Year: | N/A |
| Target Price: | $17.00 | AVG Volume (30 days): | 178.3K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.67 | EPS Growth: | -93.92 |
| 52 Week Low/High: | $17.07 - $76.42 | Next Earning Date: | 11-04-2024 |
| Revenue: | $674,475,000 | Revenue Growth: | -44.64% |
| Revenue Growth (this year): | -42.78% | Revenue Growth (next year): | -8.49% |
Latest MEDIFAST INC News
MED Breaking Stock News: Dive into MED Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Are Investors Undervaluing MEDIFAST (MED) Right Now?
Simply Wall St.
2 days ago
Medifast Third Quarter 2024 Earnings: Beats Expectations
GuruFocus.com
3 days ago
Medifast Inc (MED) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Zacks
3 days ago
MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges
Zacks
4 days ago
Medifast (MED) Beats Q3 Earnings and Revenue Estimates
Associated Press Finance
4 days ago
Medifast: Q3 Earnings Snapshot
StockStory
4 days ago
Medifast (NYSE:MED) Posts Better-Than-Expected Sales In Q3 But Quarterly Guidance Underwhelms
Business Wire
4 days ago
Medifast Announces Third Quarter 2024 Financial Results
Compare MED vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MED MEDIFAST INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.